Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125961951 | 12596195 | 1 | I | 20160715 | 20160727 | 20160727 | EXP | US-BAXTER-2016BAX038208 | BAXTER | 0.00 | F | Y | 69.40000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125961951 | 12596195 | 1 | PS | 0.9% SODIUM CHLORIDE INJECTION | SODIUM CHLORIDE | 1 | Unknown | U | 16677 | SOLUTION FOR INFUSION | |||||||||
| 125961951 | 12596195 | 2 | SS | DEXTROSE AND SODIUM CHLORIDE | DEXTROSE MONOHYDRATESODIUM CHLORIDE | 1 | Unknown | U | 16683 | SOLUTION FOR INFUSION | |||||||||
| 125961951 | 12596195 | 3 | SS | HEPARIN SODIUM AND SODIUM CHLORIDE | HEPARIN SODIUM | 1 | Unknown | STRENGTH: 10 IU/ML | U | 18609 | SOLUTION FOR INFUSION | ||||||||
| 125961951 | 12596195 | 4 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | U | 0 | 10 | MG | TABLET | Q12H | ||||||
| 125961951 | 12596195 | 5 | SS | GAMMAGARD LIQUID | HUMAN IMMUNOGLOBULIN G | 1 | Parenteral | VIA INFUSION | U | 0 | |||||||||
| 125961951 | 12596195 | 6 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | 0 | ||||||||||
| 125961951 | 12596195 | 7 | SS | DIPHENHYDRAMINE HYDROCHLORIDE. | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125961951 | 12596195 | 8 | SS | EPIPEN | EPINEPHRINE | 1 | Unknown | U | 0 | ||||||||||
| 125961951 | 12596195 | 9 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | U | 0 | TABLET | |||||||||
| 125961951 | 12596195 | 10 | SS | VITAMIN D3 | CHOLECALCIFEROL | 1 | Unknown | U | 0 | CAPSULE | |||||||||
| 125961951 | 12596195 | 11 | SS | COPAXONE | GLATIRAMER ACETATE | 1 | Unknown | U | 0 | ||||||||||
| 125961951 | 12596195 | 12 | SS | ORTHO TRI CYCLEN | ETHINYL ESTRADIOLNORGESTIMATE | 1 | Unknown | U | 0 | ||||||||||
| 125961951 | 12596195 | 13 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125961951 | 12596195 | 1 | Product used for unknown indication |
| 125961951 | 12596195 | 2 | Product used for unknown indication |
| 125961951 | 12596195 | 3 | Product used for unknown indication |
| 125961951 | 12596195 | 4 | Multiple sclerosis |
| 125961951 | 12596195 | 5 | Product used for unknown indication |
| 125961951 | 12596195 | 6 | Product used for unknown indication |
| 125961951 | 12596195 | 7 | Product used for unknown indication |
| 125961951 | 12596195 | 8 | Product used for unknown indication |
| 125961951 | 12596195 | 9 | Product used for unknown indication |
| 125961951 | 12596195 | 10 | Product used for unknown indication |
| 125961951 | 12596195 | 11 | Product used for unknown indication |
| 125961951 | 12596195 | 12 | Product used for unknown indication |
| 125961951 | 12596195 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125961951 | 12596195 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125961951 | 12596195 | Fluid overload | |
| 125961951 | 12596195 | Meningitis aseptic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125961951 | 12596195 | 4 | 20140522 | 0 |